Fundacion De Investigacion Biomedica De Salamanca

4 trials 2 recruiting Academic / non-commercial

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

1 Completed trials

1 Countries active

11 Unique IMPs

100% Results reported

Phase III

Phase II

Phase I/II

Phase IV

Phase III: 1 Phase II: 1 Phase I/II: 1 Phase IV: 1

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Cholelithiasis 1 Dry eye 1

Top IMPs

ALLOGENEIC ADIPOSE-DERIVED ADULT MESENCHYMAL STEM CELLS EXPANDED 1 ALLOGENEIC ADULT HUMAN MESENCHYMAL STEM CELLS EX-VIVO EXPANDED 1 AUTOLOGOUS BONE MARROW-DERIVED MESENCHYMAL STEM CELLS 1 BENDAMUSTINE HYDROCHLORIDE 1 CETUXIMAB 1 CYCLOPHOSPHAMIDE MONOHYDRATE 1 FLUDARABINE PHOSPHATE 1 TOCILIZUMAB 1 TRANSPOCART19 1

All trials

4 total

Clinical Trial to evaluate the efficacy and safety of cell therapy for dry eye disease in Graft-versus-Host Disease (GvHD) context. Pending

2024-519772-10-00 Phase II 1 country ALLOGENEIC ADIPOSE-DERIVED ADULT MESENCHYMAL STEM CELLS EXPANDED
LOW DOse vs standard dose and administration TIme in near-infrared fluorescence cholangiography during laparoscopic cholecystectomy: a rando… Recruiting

2025-522535-33-00 Phase IV 1 country
Phase I/IIa multicentre study of infusion of autologous peripheral blood T lymphocytes expanded and genetically modified using Sleeping Beau… Recruiting

2024-514544-90-00 Phase I/II 1 country BENDAMUSTINE HYDROCHLORIDE; CETUXIMAB; CYCLOPHOSPHAMIDE MONOHYDRATE; FLUDARABINE…
Phase III, multicentre, randomized, open clinical trial comparing treatment with allogenic mesenchymal cells against autologous mesenchymal … Ended

2024-514545-11-00 Phase III 1 country ALLOGENEIC ADULT HUMAN MESENCHYMAL STEM CELLS EX-VIVO EXPANDED; AUTOLOGOUS BONE …

Showing 1–4 of 4 trials

← All sponsors A–Z